RECRUITINGOBSERVATIONAL
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
About This Trial
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Who May Be Eligible (Plain English)
Who May Qualify:
- Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);
- Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
- Agree to participate in the study and sign the willing to sign a consent form form.
Who Should NOT Join This Trial:
- Can not sign the willing to sign a consent form form or cooperate with follow-up.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);
* Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
* Agree to participate in the study and sign the informed consent form.
Exclusion Criteria:
* Can not sign the informed consent form or cooperate with follow-up.
Treatments Being Tested
DRUG
Conservative treatment
Receive no antipaletet drug treatment and surgery
DRUG
Antipaletet drug
Use of antipaletet drugs.
PROCEDURE
Patent Foramen Ovale Closure
Receive the surgery of Patent Foramen Ovale
Locations (1)
Peking University Third Hospital
Beijing, China